Literature DB >> 29873596

Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Steven J Forrester1, George W Booz1, Curt D Sigmund1, Thomas M Coffman1, Tatsuo Kawai1, Victor Rizzo1, Rosario Scalia1, Satoru Eguchi1.   

Abstract

The renin-angiotensin-aldosterone system plays crucial roles in cardiovascular physiology and pathophysiology. However, many of the signaling mechanisms have been unclear. The angiotensin II (ANG II) type 1 receptor (AT1R) is believed to mediate most functions of ANG II in the system. AT1R utilizes various signal transduction cascades causing hypertension, cardiovascular remodeling, and end organ damage. Moreover, functional cross-talk between AT1R signaling pathways and other signaling pathways have been recognized. Accumulating evidence reveals the complexity of ANG II signal transduction in pathophysiology of the vasculature, heart, kidney, and brain, as well as several pathophysiological features, including inflammation, metabolic dysfunction, and aging. In this review, we provide a comprehensive update of the ANG II receptor signaling events and their functional significances for potential translation into therapeutic strategies. AT1R remains central to the system in mediating physiological and pathophysiological functions of ANG II, and participation of specific signaling pathways becomes much clearer. There are still certain limitations and many controversies, and several noteworthy new concepts require further support. However, it is expected that rigorous translational research of the ANG II signaling pathways including those in large animals and humans will contribute to establishing effective new therapies against various diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29873596      PMCID: PMC6335102          DOI: 10.1152/physrev.00038.2017

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  1284 in total

1.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors:  L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

Review 2.  The renin-angiotensin system and experimental heart failure.

Authors:  K C Wollert; H Drexler
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

3.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

Authors:  N Kubota; Y Terauchi; H Miki; H Tamemoto; T Yamauchi; K Komeda; S Satoh; R Nakano; C Ishii; T Sugiyama; K Eto; Y Tsubamoto; A Okuno; K Murakami; H Sekihara; G Hasegawa; M Naito; Y Toyoshima; S Tanaka; K Shiota; T Kitamura; T Fujita; O Ezaki; S Aizawa; T Kadowaki
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

4.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

Authors:  M Nawano; M Anai; M Funaki; H Kobayashi; A Kanda; Y Fukushima; K Inukai; T Ogihara; H Sakoda; Y Onishi; M Kikuchi; Y Yazaki; Y Oka; T Asano
Journal:  Metabolism       Date:  1999-10       Impact factor: 8.694

6.  Identification of a Ca2+/calmodulin-binding domain within the carboxyl-terminus of the angiotensin II (AT1A) receptor.

Authors:  W G Thomas; L Pipolo; H Qian
Journal:  FEBS Lett       Date:  1999-07-23       Impact factor: 4.124

7.  Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo.

Authors:  D E Stec; R L Davisson; R E Haskell; B L Davidson; C D Sigmund
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

8.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

9.  Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.

Authors:  S Eguchi; H Iwasaki; H Ueno; G D Frank; E D Motley; K Eguchi; F Marumo; Y Hirata; T Inagami
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

Authors:  Y Tsutsumi; H Matsubara; H Masaki; H Kurihara; S Murasawa; S Takai; M Miyazaki; Y Nozawa; R Ozono; K Nakagawa; T Miwa; N Kawada; Y Mori; Y Shibasaki; Y Tanaka; S Fujiyama; Y Koyama; A Fujiyama; H Takahashi; T Iwasaka
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

View more
  244 in total

Review 1.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

2.  Smooth Muscle Cell-Specific Disruption of the BBSome Causes Vascular Dysfunction.

Authors:  John J Reho; Deng-Fu Guo; Donald A Morgan; Kamal Rahmouni
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

3.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 4.  Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.

Authors:  Seonwook Kim; Venkateswaran Subramanian; Ahmed Abdel-Latif; Sangderk Lee
Journal:  Metab Syndr Relat Disord       Date:  2020-02-20       Impact factor: 1.894

5.  Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.

Authors:  Akihiro Kuma; Xiaonan H Wang; Janet D Klein; Lin Tan; Nawazish Naqvi; Fitra Rianto; Ying Huang; Manshu Yu; Jeff M Sands
Journal:  FASEB J       Date:  2020-05-04       Impact factor: 5.191

6.  Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity.

Authors:  Diego T Quiroga; Johanna G Miquet; Lorena Gonzalez; Ana I Sotelo; Marina C Muñoz; Pedro M Geraldes; Jorge F Giani; Fernando P Dominici
Journal:  Mol Cell Endocrinol       Date:  2019-09-17       Impact factor: 4.102

7.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

8.  Early Morphofunctional Changes in AngII-Infused Mice Contribute to Regional Onset of Aortic Aneurysm and Dissection.

Authors:  Lydia Aslanidou; Bram Trachet; Linda Sasset; Goran Lovric; Nikolaos Stergiopulos; Annarita Di Lorenzo
Journal:  J Vasc Res       Date:  2020-09-16       Impact factor: 1.934

9.  Angiotensin II- and Alzheimer-Type Cardiovascular Aging.

Authors:  Hannah A Cooper; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 10.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.